Effect of 5-fluorouracil treatment on SN-38 absorption from intestine in rats

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 9, 2011, Pages 1418-1425

  Shibayama, Yoshihiko ^a   Iwashita, Yoshitaka ^b   Yoshikawa, Yoshimi ^c   Kondo, Tomoko ^d   Ikeda, Ryuji ^d   Takeda, Yasuo ^d   Osada, Takayuki ^a   Sugawara, Mitsuru ^a   Yamada, Katsushi ^d   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Akune Citizen Hospital   (Japan)

^c Takada Hospital   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

5 Fluorouracil; Absorption; Diarrhea; Irinotecan; Neutropenia; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; BREAST CANCER RESISTANCE PROTEIN; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID X RECEPTOR; FLUOROURACIL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; PREGNANE X RECEPTOR; PROTEIN C JUN; RETINOID X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG TRANSPORT; ELECTROPHORESIS; EMBRYO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MALE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BODY WEIGHT; CAMPTOTHECIN; CELL LINE; DNA PRIMERS; FLUOROURACIL; HUMANS; INTESTINAL ABSORPTION; MALE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 80052442485     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1418     Document Type: Article

References (43)

1. Pinedo H. M., Peters G. F., J. Clin. Oncol., 6, 1653-1664 (1988).
2. Rich T. A., Shepard R. C., Mosley S. T., J. Clin. Oncol., 22, 2214-2232 (2004).
3. Malet-Martino M., Martino R., Oncologist, 7, 288-323 (2002).
4. McLeod H. L., Sludden J., Hardy S. C., Lock R. E., Hawksworth G. M., Cassidy J., Eur. J. Cancer, 34, 1623-1627 (1998).
5. Peters G. J., Van der Wilt C. L., Van Moorsel C. J., Kroep J. R., Bergman A. M., Ackland S. P., Pharmacol. Ther., 87, 227-253 (2000).
6. Wolpin B. M., Mayer R. J., Gastroenterology, 134, 1296-1310 (2008).
7. Douillard J. Y., Cunningham D., Roth A. D., Navarro M., James R. D., Karasek P., Jandik P., Iveson T., Carmichael J., Alakl M., Gruia G., Awad L., Rougier P., Lancet, 355, 1041-1047 (2000).
8. Cunningham D., Pyrhönen S., James R. D., Punt C. J., Hickish T. F., Heikkila R., Johannesen T. B., Starkhammar H., Topham C. A., Awad L., Jacques C., Herait P., Lancet, 352, 1413-1418 (1998).
9. Rougier P., Van Cutsem E., Bajetta E., Niederle N., Possinger K., Labianca R., Navarro M., Morant R., Bleiberg H., Wils J., Awad L., Herait P., Jacques C., Lancet, 352, 1407-1412 (1998).
10. Chu X. Y., Kato Y., Ueda K., Suzuki H., Niinuma K., Tyson C. A., Weizer V., Dabbs J. E., Froehlich R., Green C. E., Sugiyama Y., Cancer Res., 58, 5137-5143 (1998).
11. Dietrich C. G., Geier A., Oude Elferink R. P., Gut, 52, 1788-1795 (2003).
12. König J., Nies A. T., Cui Y., Leier I., Keppler D., Biochim. Biophys. Acta, 1461, 377-394 (1999).
13. Gerk P. M., Vore M., J. Pharmacol. Exp. Ther., 302, 407-415 (2002).
14. Payen L., Sparfel L., Courtois A., Vernhet L., Guillouzo A., Fardel O., Cell Biol. Toxicol., 18, 221-233 (2002).
15. Shibayama Y., Ikeda R., Motoya T., Yamada K., Food Chem. Toxicol., 42, 995-1002 (2004).
16. Shibayama Y., Ushinohama K., Ikeda R., Yoshikawa Y., Motoya T., Takeda Y., Yamada K., Cancer Sci., 97, 1260-1266 (2006).
17. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M., Cell, 54, 541-552 (1988).
18. Geier A., Mertens P. R., Gerloff T., Dietrich C. G., En-Nia A., Kullak-Ublick G. A., Karpen S. J., Matern S., Gartung C., Biochem. Biophys. Res. Commun., 309, 612-618 (2003).
19. Kauffmann H. M., Schrenk D., Biochem. Biophys. Res. Commun., 245, 325-331 (1998).
20. Cecchin E., Corona G., Masier S., Biason P., Cattarossi G., Frustaci S., Buonadonna A., Colussi A., Toffoli G., Clin. Cancer Res., 11, 6901-6907 (2005).
21. Ikeda R., Che X. F., Yamaguchi T., Ushiyama M., Zheng C. L., Okumura H., Takeda Y., Shibayama Y., Nakamura K., Jeung H. C., Furukawa T., Sumizawa T., Haraguchi M., Akiyama S., Yamada K., Cancer Sci., 96, 372-376 (2005).
22. Albermann N., Schmitz-Winnenthal F. H., Z'graggen K., Volk C., Hoffmann M. M., Haefeli W. E., Weiss J., Biochem. Pharmacol., 70, 949-958 (2005).
23. Payen L., Courtois A., Loewert M., Guillouzo A., Fardel O., Biochem. Biophys. Res. Commun., 282, 257-263 (2001).
24. Pinkel D., Cancer Res., 18, 853-856 (1958).
25. André T., Louvet C., Maindrault-Goebel F., Couteau C., Mabro M., Lotz J. P., Gilles-Amar V., Krulik M., Carola E., Izrael V., De Gramont A., Eur. J. Cancer, 35, 1343-1347 (1999).
26. Venook A., Oncologist, 10, 250-261 (2005).
27. Zhang Y., Zhao T., Li W., Vore M., Mol. Pharmacol., 77, 237-246 (2010).
28. Li D., Ueta E., Kimura T., Yamamoto T., Osaki T., Cancer Sci., 95, 644-650 (2004).
29. Demeule M., Brossard M., Turcotte S., Regina A., Jodoin J., Béliveau R., Biochem. Biophys. Res. Commun., 324, 937-945 (2004).
30. Tanaka T., Uchiumi T., Hinoshita E., Inokuchi A., Toh S., Wada M., Takano H., Kohno K., Kuwano M., Hepatology, 30, 1507-1512 (1999).
31. Jones S. A., Moore L. B., Shenk J. L., Wisely G. B., Hamilton G. A., McKee D. D., Tomkinson N. C., LeCluyse E. L., Lambert M. H., Willson T. M., Kliewer S. A., Moore J. T., Mol. Endocrinol., 14, 27-39 (2000).
32. Willson T. M., Jones S. A., Moore J. T., Kliewer S. A., Med. Res. Rev., 21, 513-522 (2001).
33. Dietrich C. G., Geier A., Oude Elferink R. P., Gut, 12, 1788-1795 (2003).
34. Wendling J., Marchand A., Mauviel A., Verrecchia F., Mol. Pharmacol., 64, 707-713 (2003).
35. Trauner M., Arrese M., Soroka C. J., Ananthanarayanan M., Koeppel T. A., Schlosser S. F., Suchy F. J., Keppler D., Boyer J. L., Gastroenterology, 113, 255-264 (1997).
36. Alimonti A., Gelibter A., Pavese I., Satta F., Cognetti F., Ferretti G., Rasio D., Vecchione A., Di Palma M., Cancer Treat. Rev., 30, 555-562 (2004).
37. Klaassen C. D., Lu H., Toxicol. Sci., 101, 186-196 (2008).
38. Chu X. Y., Suzuki H., Ueda K., Kato Y., Akiyama S., Sugiyama Y., J. Pharmacol. Exp. Ther., 288, 735-741 (1999).
39. Nakatomi K., Yoshikawa M., Oka M., Ikegami Y., Hayasaka S., Sano K., Shiozawa K., Kawabata S., Soda H., Ishikawa T., Tanabe S., Kohno S., Biochem. Biophys. Res. Commun., 288, 827-832 (2001).
40. Korenaga D., Honda M., Yasuda M., Inutsuka S., Nozoe T., Tashiro H., Eur. Surg. Res., 34, 351-356 (2002).
41. Van Waterschoot R. A., Lagas J. S., Wagenaar E., Rosing H., Beijnen J. H., Schinkel A. H., Int. J. Cancer, 127, 2959-2964 (2010).
42. Van Waterschoot R. A., ter Heine R., Wagenaar E., Van der Kruijssen C. M., Rooswinkel R. W., Huitema A. D., Beijnen J. H., Schinkel A. H., Br. J. Pharmacol., 160, 1224-1233 (2010).
43. Yoshisue K., Nagayama S., Shindo T., Kawaguchi Y., J. Pharmacol. Exp. Ther., 297, 1166-1175 (2001).